[go: up one dir, main page]

NO934832D0 - Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose - Google Patents

Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose

Info

Publication number
NO934832D0
NO934832D0 NO934832A NO934832A NO934832D0 NO 934832 D0 NO934832 D0 NO 934832D0 NO 934832 A NO934832 A NO 934832A NO 934832 A NO934832 A NO 934832A NO 934832 D0 NO934832 D0 NO 934832D0
Authority
NO
Norway
Prior art keywords
arterioscerosis
prevention
treatment
pharmaceutical composition
pharmaceutical
Prior art date
Application number
NO934832A
Other languages
English (en)
Other versions
NO934832L (no
Inventor
Yusuke Satoh
Toshifumi Inami
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO934832D0 publication Critical patent/NO934832D0/no
Publication of NO934832L publication Critical patent/NO934832L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO934832A 1992-12-28 1993-12-27 Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose NO934832L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34747692A JP3465247B2 (ja) 1992-12-28 1992-12-28 動脈硬化症の予防および治療剤

Publications (2)

Publication Number Publication Date
NO934832D0 true NO934832D0 (no) 1993-12-27
NO934832L NO934832L (no) 1994-06-29

Family

ID=18390484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934832A NO934832L (no) 1992-12-28 1993-12-27 Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose

Country Status (12)

Country Link
US (1) US5416105A (no)
EP (1) EP0604853A3 (no)
JP (1) JP3465247B2 (no)
KR (1) KR940013503A (no)
CN (1) CN1104888A (no)
AU (1) AU666992B2 (no)
CA (1) CA2112195A1 (no)
HU (1) HUT69398A (no)
IL (1) IL108197A0 (no)
NO (1) NO934832L (no)
PL (1) PL301653A1 (no)
ZA (1) ZA939707B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631275A (en) * 1993-12-30 1997-05-20 Hoechst Aktiengesellschaft Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
WO1997002036A1 (en) * 1995-06-30 1997-01-23 Zymogenetics, Inc. 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists
KR100413745B1 (ko) * 1995-08-30 2004-03-20 정규범 컨버터스위치의스위칭손실및노이즈저감회로
DE60219963T2 (de) * 2002-01-25 2008-02-07 Laboratorios Silanes, S.A. De C.V. Pharmazeutische zusammensetzung, die zur glukosekontrolle im blut von patienten mit diabetes typ 2 eingesetzt wird
KR101152729B1 (ko) 2003-09-17 2012-06-15 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 메카니즘-기초 표적화된 췌장 베타 세포 영상화 및 치료법
KR100698595B1 (ko) * 2003-09-29 2007-03-21 보령제약 주식회사 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물
DE102005034484A1 (de) * 2005-07-20 2007-02-01 Alfred E. Tiefenbacher Gmbh & Co.Kg Verfahren zur Herstellung von Glimepirid enthaltenden pharmazeutischen Zusammensetzungen
MXPA05009633A (es) * 2005-09-08 2007-03-07 Silanes Sa De Cv Lab Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
TR201101809A1 (tr) 2010-12-21 2012-07-23 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Vildagliptin ve glimepirid kombinasyonları.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2951135A1 (de) * 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4411903A (en) * 1980-08-11 1983-10-25 American Cyanamid Company 4-[(Monosubstituted-alkyl)amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents
CA1339784C (en) * 1988-06-23 1998-03-31 Shinya Inoue Pyrrolecarboxylic acid derivatives

Also Published As

Publication number Publication date
AU666992B2 (en) 1996-02-29
IL108197A0 (en) 1994-04-12
PL301653A1 (en) 1994-07-11
US5416105A (en) 1995-05-16
CA2112195A1 (en) 1994-06-29
KR940013503A (ko) 1994-07-15
AU5270693A (en) 1994-07-07
JP3465247B2 (ja) 2003-11-10
NO934832L (no) 1994-06-29
JPH06192088A (ja) 1994-07-12
HUT69398A (en) 1995-09-28
ZA939707B (en) 1994-08-29
HU9303758D0 (en) 1994-04-28
EP0604853A3 (en) 1994-08-24
EP0604853A2 (en) 1994-07-06
CN1104888A (zh) 1995-07-12

Similar Documents

Publication Publication Date Title
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
NO995500L (no) Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi
NO932791L (no) Fremgangsmaate for fremstilling av titandioksyd
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
FI930860A7 (fi) Tropolonijohdoksia ja niiden farmaseuttisia koostumuksia iskeemisten s airauksien ehkäisemiseen ja hoitamiseen
AU3899893A (en) Compositions for the treatment of acute or chronic inflammation
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
FI961380A7 (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitam iseksi
ITRM920222A0 (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
NO932850L (no) Fremgangsmaate for fremstilling av staal
IL105406A0 (en) Derivatives of adipogenesis inhibitory factor,processes for the preparation thereof and pharmaceutical compositions containing the same
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
FI944687L (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
AP9700928A0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections
NO933451D0 (no) Ekstruder for dosering av kunststoff eller kunststoffblandinger
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
NO308883B1 (no) Anvendelse av lignanderivater ved fremstilling av farmasøytiske preparater for behandling av amyloidosetilstander
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives